Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 25;31(33):9198-204.
doi: 10.1021/acs.langmuir.5b01833. Epub 2015 Aug 11.

Complete Exchange of the Hydrophobic Dispersant Shell on Monodisperse Superparamagnetic Iron Oxide Nanoparticles

Affiliations

Complete Exchange of the Hydrophobic Dispersant Shell on Monodisperse Superparamagnetic Iron Oxide Nanoparticles

Oliver Bixner et al. Langmuir. .

Abstract

High-temperature synthesized monodisperse superparamagnetic iron oxide nanoparticles are obtained with a strongly bound ligand shell of oleic acid and its decomposition products. Most applications require a stable presentation of a defined surface chemistry; therefore, the native shell has to be completely exchanged for dispersants with irreversible affinity to the nanoparticle surface. We evaluate by attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) and thermogravimetric analysis/differential scanning calorimetry (TGA/DSC) the limitations of commonly used approaches. A mechanism and multiple exchange scheme that attains the goal of complete and irreversible ligand replacement on monodisperse nanoparticles of various sizes is presented. The obtained hydrophobic nanoparticles are ideally suited for magnetically controlled drug delivery and membrane applications and for the investigation of fundamental interfacial properties of ultrasmall core-shell architectures.

PubMed Disclaimer

Figures

Figure 1
Figure 1
TEM of spherical, monodisperse magnetite nanoparticles with narrow size distributions of (a) 3.5 ± 0.4 nm, (b) 5.0 ± 0.4 nm, and (c) 8.3 ± 0.4 nm and (d) high-resolution (HR)-TEM of the 8.3 ± 0.4 nm SPIONs in panel c.
Figure 2
Figure 2
ATR–FTIR spectra of various 3.5 nm magnetite nanoparticle preparations: (a) as-synthesized SPION containing excess physisorbed OA, (b) purified SPION with a monolayer of chemisorbed oleate, (c–j) mixed dispersant OA/P-NDA–SPION and (l–m) post-coated, pure nitrocatechol-ligand-capped SPIONs. SPIONs were purified by the following methods: (b) pre-extraction in hot MeOH containing 1 mM OA as a stabilizer, (c) hot MeOH extraction, (d) cold MeOH extraction, (e) syringe filtration (PTFE), (f) surfactant addition (CTAB), (g) silica column chromatography (THF/MeOH = 4:1), (h) ligand saturated chromatography, (i) repeated MeOH/n-hexane (1:1) recrystallization, (j) 2,6-lutidine as a solvent, (k) post-coated P-NDA–SPION, (l) post-coated d31P-NDA–SPION, (m) post-coated NDA–SPION, and (n) SPION with combusted shell (post-TGA) with 10× scaled inset of residual absorptions. Peaks corresponding to physisorbed and chemisorbed OA are indicated by circles and asterisks, respectively, while crosses depict bands related to nitrocatechol ligands. The post-coated P-NDA (k), d31P-NDA (l), and NDA particles (m) are the only particles that demonstrate an absence of the characteristic OA bands and, therefore, complete ligand replacement.
Figure 3
Figure 3
TGA (solid lines) and DSC curves (dashed lines) of representative 3.5 nm SPION preparations measured in synthetic air: as-synthesized OA–SPION containing excess physisorbed oleic acid (black, stars), purified OA–SPION with an oleate monolayer (gray, squares), column-chromatographed SPION with physisorbed impurities (magenta, diamonds), cold MeOH-extracted mixed dispersant SPION containing around 5% w/w physisorbed OA (green, triangles), CTAB-treated mixed dispersant SPION free of physisorbed OA (blue, circles), and spectroscopically clean P-NDA post-coated SPION (red, triangles).

References

    1. Amstad E.; Textor M.; Reimhult E. Stabilization and Functionalization of Iron Oxide Nanoparticles for Biomedical Applications. Nanoscale 2011, 372819–2843 10.1039/c1nr10173k. - DOI - PubMed
    1. Liu G.; Gao J.; Ai H.; Chen X. Applications and Potential Toxicity of Magnetic Iron Oxide Nanoparticles. Small 2013, 99–101533–1545 10.1002/smll.201201531. - DOI - PubMed
    1. Ling D.; Hyeon T. Iron Oxide Nanoparticles: Chemical Design of Biocompatible Iron Oxide Nanoparticles for Medical Applications (Small 9–10/2013). Small 2013, 99–101449–1449 10.1002/smll.201370057. - DOI - PubMed
    1. Kim B. H.; Lee N.; Kim H.; An K.; Park Y. I.; Choi Y.; Shin K.; Lee Y.; Kwon S. G.; Na H. B.; et al. Large-Scale Synthesis of Uniform and Extremely Small-Sized Iron Oxide Nanoparticles for High-Resolution T1Magnetic Resonance Imaging Contrast Agents. J. Am. Chem. Soc. 2011, 1333212624–12631 10.1021/ja203340u. - DOI - PubMed
    1. Laurent S.; Dutz S.; Häfeli U. O.; Mahmoudi M. Magnetic Fluid Hyperthermia: Focus on Superparamagnetic Iron Oxide Nanoparticles. Adv. Colloid Interface Sci. 2011, 1661–28–23 10.1016/j.cis.2011.04.003. - DOI - PubMed

Publication types

MeSH terms